Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 9, 2002, Pages 699-705

  Della Casa, Vera ^a   Noll, Harald ^a   Gonser, Susanne ^a   Grob, Philipp ^a   Graf, Federico ^a   Pohlig, Gabriele ^a  

^a Medinova Ltd   (Switzerland)

Author keywords

CAS 25655 41 8; CAS 522 51 0; Dequalinium chloride, antimicrobial activity, minimum inhibitory concentration; Povidone iodine; Trichomonas vaginalis; Vaginal infections

Indexed keywords

CLOTRIMAZOLE; DEQUALINIUM;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEROIDES; CANDIDA; CONCENTRATION RESPONSE; ENTEROCOCCUS; ESCHERICHIA COLI; GARDNERELLA; LISTERIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PORPHYROMONAS; PREVOTELLA; PROTEUS; PROTEUS MIRABILIS; STAPHYLOCOCCUS; STREPTOCOCCUS; TRICHOMONAS; TRICHOMONAS VAGINALIS; VAGINITIS;

EID: 0036380792     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299954     Document Type: Article

References (45)

1. Fanta, D., Messeritsch, H., Behandlungsergebnis mit Dequaliniumhydrochlorid bei verschiedenen Dermatosen. Castellania 1, 113 (1973)
2. Barge, H., Werkärztliche Erfahrungen mit Dequaliniumchlorid bei der Behandlung von entzündlichen Erkrankungen der Mund- und Rachenhöhle. Dtsch. Med. J. 19, 51 (1968)
3. Gürtler, J. E., Erfahrungen mit Decatylen bei entzündlichen Erkrankungen des Rachenraumes. Ther. Umschau 4, 157 (1966)
4. Klinger, J., Klinger, A., Dequonal, ein neues Mund- und Rachenantiseptikum in der Stomatologie. Zahnärztl. Welt/Reform 87, 802 (1978)
5. Lange, D. E., Diagnostik und Therapie von akuten Gingivitiden, Parodontitiden, Parodontalabszessen, vesicobullösen und desquamativen Stomatididen (Teil I). Quintessenz 32, 1079 (1981a)
6. Lange, D. E., Diagnostik und Therapie von akuten Gingivitiden, Parodontitiden, Parodontalabszessen, vesicobullösen und desquamativen Stomatitiden (Teil II). Quintessenz 32, 1259 (1981b)
7. Roddie, T. W., Clinical evaluation of dequadin in the treatment of vaginal infections and infestations. Med. J. Malaya 13, 171 (1958)
8. Strecker, M., Hokemohr, H., Teucher, T. et al., Antiseptika gegen Vulvovaginiden. TW Gynäkologie 6, 409 (1993)
9. Mühlbauer, W., Behandlung des infektiösen Fluors mit Dequavagyn®. Therapiewoche 22, 1414 (1972)
10. Tatra, G., Behandlung des infektiösen Fluors mit Dequavagyn® (Dequaliniumchlorid). Münch. Med. Wochenschr. 114, 773 (1972)
11. Martin, J., Martin, R., Therapie genitaler Mykosen mit Dequavagyn. In: Dermatomykosen und Endomykosen, H. Grimmer, H. Rieth, Grosse Verlag, Berlin (1971)
12. Petersen, E. E., Weissenbacher, E. R., Hengst, P. et al., Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. Arzneim.- Forsch./Drug Res. 52, 706 (2002)
13. Levinson, D. R., Dequalinium in the treatment of trichomoniasis in woman. Practitioner 183, 195 (1959)
14. Merianos, J. J., Quarternary ammonium antimicrobial compounds. Disinfection, Sterilization, and Preservation. Block SS, 4th ed., pp 225-255, Lea & Febiger, Philadelphia-London (1991)
15. Marghescu, S., Zur Behandlung bakterieller und mykotischer Hautinfektionen in den intertriginösen Räumen. Ther. Gegenwart 114, 427 (1975)
16. Wunderer, H., Mund- und Rachentherapeutika. Dtsch. Apoth. Ztg. 126, 2281 (1986)
17. Antiseptika. In: B. Bornkessel, H. Hamacher, Selbstmedikation, 5. Erg. Lfg., pp B.8/5-B.8/17, Deutscher Apotheker Verlag, Stuttgart (1996)
18. Dequalinium chlorure, monograph Bundesinstitut für Arzneimittel und Medizinprodukte, Berlin (1998)
19. Brauss, F. W., Rieth, H., Wirksamkeit von Dekamethylenaminochinaldiniumchlorid gegenüber pathogenen Mikroorganismen. Münch. Med. Wochenschr. 116, 1519 (1974)
20. Babbs, M., Collier, H. O. J., Austin, W. C. et al., Salts of decamethylene-bis-4-aminoquinaldinium ("Dequadin"), a new antimicrobial agent. J. Pharm. Pharmacol. 8, 110 (1956)
21. Collier, H. O. J., Cox, W. A., Huskinson, P. L. et al., Further observations on the biological properties of dequalinium (Dequadin) and hedaquinium (Teoquil). J. Pharm. Pharmacol. 11, 671 (1959)
22. Cox, W. A., D'Arcy, P. F., The activity of polymethylenebis-4-aminoquinaldinium salts against Pityrosporum ovale and Candida albicans. J. Pharm. Pharmacol. 13, 34 (1961)
23. D'Auria, F. D., Simonetti, G., Strippoli, V., Caratteristische antimicrobiche di una tintura al dequalinio cloruro. Ann. Ig. 1, 1227 (1989)
24. Jeng, D. K., Severin, J. E., Povidone iodine gel alcohol: a 30-second, onetime application preoperative skin preparation. Am. J. Infect. Control 26, 488 (1998)
25. Scott, E. M., Gorman, S. P., McGrath, S. J., An assessment of the fungicidal activity of antimicrobial agents used for hard-surface and skin disinfection. J. Clin. Hosp. Pharm. 11, 199 (1986)
26. Yu, H., Tak-Yin, M., The efficacy of povidone-iodine pressaries in a short, low-dose treatment regime on candidal, trichomonal and non-specific vaginitis. Postgrad. Med. J. 69 (Suppl. 3), S58 (1993)
27. Harris, P. G., Clinical experience with povidone-iodine vaginal pessaries in the treatment of non-specific vaginitis. Practitioner 209, 828 (1972)
28. Martindaie, The Extra Pharmacopoeia, 31st Pharmaceutical Press, London (1996)
29. Goode, M. A., Grauer, K., Gums, J. G., Infectious vaginitis. Selecting therapy and preventing recurrence. Postgrad. Med. J. 96, 85 (1994)
30. Legal, H.-P., The treatment of trichomonas and candida vaginitis with clotrimazole vaginal tablets. Postgrad. Med. J. 50, 81 (1974)
31. Donders, G. G., Vereecken, A., Bosmanns, E. et al., Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Brit. J. Obstet. Gynecol. 109, 1 (2002)
32. Hill, G. B., The microbiology of bacterial vaginosis. Am. J. Obstet. Gynecol. 169, 450 (1993)
33. Fuursted, K., Hjort, A., Knudsen, L., Evaluation of bactericidal activity and lag of regrowth (postantibiotic effect) of five antiseptics on nine bacterial pathogens. J. Antimicrob. Chemother. 40, 221 (1997)
34. Ferrer, J., Vaginal candidosis: epidemiological and ethiological factors. Int. J. Gynecol. Obstet. 71, S21 (2000)
35. Schmidt, A., In vitro activity of clotrimazole for Candida strains isolated from recent patient samples. Arzneim.-Forsch./Drug Res. 45, 1338 (1995)
36. Sobel, J. D., Antimicrobial resistance in vulvovaginitis. Curr. Infect. Dis. Rep. 3, 546 (2001)
37. Elkhouly, A. E., Effect of quenching agents on the activity of nystatin against Candida albicans. Mykosen 21, 300 (1978)
38. Henderson, J. N., Tait, I. B., The use of povidone-iodine ("Betadine") pessaries in the treatment of candidal and trichomonal vaginitis. Curr. Med. Res. Opin. 3, 157 (1975)
39. Resch, B. A., Szanto, F., Local treatment of colpitis with Betadine® vaginal suppository. Ther. Hung. 41, 137 (1993)
40. Schook, D. M., A clinical study of a povidone-iodine regimen for resistant vaginitis. Curr. Ther. Res. 5, 256 (1993)
41. Wong, C. A., Wilson, P. D., Chew, T. A., Povidone-iodine in the treatment of metronidazole-resistant Trichomonas vaginalis. Aust. N. Z. J. Obstet. Gynaecol. 30, 169 (1990)
42. Lossick, J. G., Kent, H. L., Trichomoniasis: Trends in diagnosis and management. Am. J. Obstet. Gynecol. 165, 1217 (1991)
43. James, J. A., Thomason, J. L., Gelbart, S. M. et al., Is trichomoniasis often associated with bacterial vaginosis in pregnant adolescents? Am. J. Obstet. Gynecol. 166, 859 (1992)
44. Franklin, T. L., Monif, G. R. G., Trichomonas vaginalis and bacterial vaginosis. Coexistence in vaginal wet mount preparations from pregnant women. J. Reprod. Med. 45, 131 (2000)
45. Adam, D., Antibakterielle Chemotherapie mit Antibiotika. In: Klinische Pharmakologie, 4th ed.; H. P. Kuemmerle, G. Hitzenberger, K. H. Spitzy(eds.), ch. IV-5.1, Ecomed Verlagsgesellschaft, Landsberg (1989)